Search results
Results from the WOW.Com Content Network
Natamycin, also known as pimaricin, is an antifungal medication used to treat fungal infections around the eye. [1] [2] This includes infections of the eyelids, conjunctiva, and cornea. [1] It is used as eyedrops. [1] Natamycin is also used in the food industry as a preservative. [2] Allergic reactions may occur. [1]
Stye of the upper eyelid 8-year-old boy with an external hordeolum of lower lid. The first sign of a stye is a small, yellowish spot at the center of the bump that develops as pus and expands in the area. [7] Other stye symptoms may include: A lump on the top or bottom eyelid; Localized swelling of the eyelid; Localized pain; Redness; Tenderness
BCEM, also referred to as conjunctival hypermelanosis, complexion-associated melanosis, or racial melanosis, is a non-cancerous lesion of the conjunctiva that is more commonly found in dark-skinned individuals (over 90% of lesions are found in black persons and around 5% in white persons). [1]
Trachoma is an infectious disease caused by bacterium Chlamydia trachomatis. [2] The infection causes a roughening of the inner surface of the eyelids. [2] This roughening can lead to pain in the eyes, breakdown of the outer surface or cornea of the eyes, and eventual blindness. [2]
Seborrhoeic dermatitis on upper face/head Seborrhoeic dermatitis on the shoulder Seborrhoeic dermatitis on eyelids Seborrhoeic dermatitis on the eyebrows and scalp. Seborrhoeic dermatitis typically appears as dry, white, flaky skin. The flakes can be fine, loose, and diffuse or thick and adherent.
That news follows the Social Security Administration’s announcement of a 2.5% cost-of-living adjustment (COLA) for 2025, which will add about $50 to the average monthly benefit of roughly $1,900 ...
The market is underestimating how much the Federal Reserve's will cut rates in 2025, Goldman Sachs says. The Fed fund rate will drop to 3.25-3.50% by the end of 2025, the bank estimates.
From January 2008 to December 2012, if you bought shares in companies when Peter C. Wendell joined the board, and sold them when he left, you would have a -29.6 percent return on your investment, compared to a -2.8 percent return from the S&P 500.